Comparative diagnostic performance of ultrasound and magnetic resonance imaging for predicting microvascular invasion in hepatocellular carcinoma: a head-to-head meta-analysis.

Eur J RadiolJul 16, 2026 (epub)

Jujun Shi, Feng Xiao, Jiahui Liao et al.

✦ AI-curated · Sources linked

In 30 seconds

This meta-analysis evaluated the diagnostic performance of ultrasound (US) and magnetic resonance imaging (MRI) for predicting microvascular invasion (MVI) in hepatocellular carcinoma (HCC) across five studies involving 771 patients. The combined US + MRI model demonstrated a pooled sensitivity of 0.87 and specificity of 0.86, significantly outperforming both modalities alone.

Key findings

  • Pooled sensitivity for US was 0.78, while for MRI it was 0.90.
  • The combined US + MRI model had a pooled sensitivity of 0.87 and specificity of 0.86.
  • The area under the curve (AUC) for the combined model was 0.93, significantly higher than US and MRI alone.

Why it matters

Accurate preoperative prediction of microvascular invasion in HCC is crucial for treatment planning. This study suggests that combining imaging modalities can enhance diagnostic accuracy, potentially improving patient outcomes.

Source

Published in Eur J Radiol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Gastroenterology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.